方盛制药 (603998)
Hunan Fangsheng Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 43908.14
- Circulating A-Shares(W): 43908.14
- Earnings Per Share(RMB): 0.6100
- Net Assets Per Share(RMB): 3.8080
- Operating Revenue(W RMB): 125331.53
- Total Profit(W RMB): 29916.25
- **Net Profit Attributable to Parent(W RMB) **: 26828.33
- Net Profit Growth Rate(%): 17.60
- Weighted Return on Equity(%): 15.7100
- Operating Cash Flow Per Share(RMB): 0.5120
- Undistributed Profit Per Share(RMB): 2.1082
- Capital Reserve Per Share(RMB): 0.3404
2. Main Business
The main business covers:
- Cardiovascular and cerebrovascular proprietary Chinese medicines
- Orthopedic medicines
- Pediatric medicines
- Anti-infective medicines
3. Company Basic Information
- Company Name: Hunan Fangsheng Pharmaceutical Co., Ltd.
- Listing Date: 2014-12-05
- Industry: Pharmaceuticals & Healthcare - Traditional Chinese Medicine
- Address: No. 789, Lusong Road, High-tech Zone, Changsha City, Hunan Province
- Website: https://www.fangsheng.com.cn/
- Company Profile: Hunan Fangsheng Pharmaceutical Co., Ltd. was formerly known as Changsha Health Beverage Factory established in 1983. The factory was renamed Changsha Health Pharmaceutical Factory in 1989, transformed into a corporate enterprise in 2000, and wholly changed to a joint stock company in 2009. On September 29, 2009, the company completed the industrial and commercial change registration with the Hunan Provincial Administration for Industry and Commerce and obtained a new business license with registration number 430000000017049. On June 29, 2010, the company held a shareholders' meeting and agreed that Jiuding Pharmaceutical would increase capital by RMB 60 million in cash, corresponding to an additional 12.2648 million shares of the company. On August 2, 2010, the company signed a corresponding "Capital Increase and Share Expansion Agreement" with Jiuding Pharmaceutical. On August 19, 2010, the company completed the industrial and commercial registration for the above changes with the Hunan Provincial Administration for Industry and Commerce and obtained a new business license.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Taizhou Gongsheng Consulting Co., Ltd. | General Legal Person | 913.18 | 2.08 |
| 2 | Rongtong Health Industry Flexible Allocation Hybrid Securities Investment Fund - Class A | Fund | 750.00 | 1.71 |
| 3 | Rongtong China Wind No.1 Flexible Allocation Hybrid Securities Investment Fund - Class A | Fund | 600.00 | 1.37 |
| 4 | Changxin Jinli Trend Mixed Securities Investment Fund - Class A | Fund | 500.00 | 1.14 |
| 5 | CITIC Securities Construction Investment Industry Rotation Hybrid Securities Investment Fund - Class A | Fund | 371.60 | 0.85 |
| 6 | Guotai Jinniu Innovation Growth Hybrid Securities Investment Fund | Fund | 300.00 | 0.68 |
| 7 | Ping An Fund - Ping An Life Insurance Company of China, Ltd. - Dividend - Individual Insurance Dividend - Ping An Life - Ping An Fund Equity Mandate Investment No. 2 Single Asset Management Plan | Asset Management Plan | 286.07 | 0.65 |
| 8 | CITIC Securities Construction Investment Value Selection Hybrid Securities Investment Fund - Class A | Fund | 234.56 | 0.53 |
| 9 | Rongtong Xinxin Growth Hybrid Securities Investment Fund - Class A | Fund | 160.00 | 0.36 |
| 10 | CITIC Securities Construction Investment Strategy Selection Hybrid Securities Investment Fund - Class A | Fund | 135.38 | 0.31 |
5. Concept Sectors
- Baby & Child Concept
- Elderly Care Concept
- Private Hospitals
- Industrial Hemp
- Hepatitis Concept
- Innovative Drugs
- Synthetic Biology
Remarks
- Data update date: 2025-09-30
- Data source: Public market information